ODE-500

TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA (PH+ CML) IN CHRONIC PHASE (CP), EXCLUDING PATIENTS PREVIOUSLY TREATED WITH TWO OR MORE TYROSINE KINASE INHIBITORS (TKIS), AND EXCLUDING PATIENTS